
Regeneron, Parabilis Ink Up-to-$2.3B Antibody-Peptide Conjugate Collaboration
@Regeneron will partner with #ParabilisMedicines to develop an initial five candidates of #ADCs aimed at challenging and historically undruggable targets
#antibodies #peptides
hubs.li/Q04hjQkz0
English




